New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the product. This is […]
Advanced Analytical Technologies, Inc. (AATI) is excited to announce the release of myFRAG Online, your companion to the AATI family of instruments. Sign-up for a free account and register your instrument(s) to have important resources at your fingertips, from User Manuals and Ladder Profiles, to Safety Data Sheets and PROSize® Data Analysis Software updates. To […]
HUNTSVILLE, Ala.–Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing (NGS)-based assays, today announced it has entered into a co-marketing agreement with Illumina, Inc. (NASDAQ: ILMN). Under the terms of the agreement, Illumina will market and promote the Kailos TargetRich™ line of research solutions for pharmacogenetics targets through its […]
Fabric Genomics, a global computational genomics company, and Sentieon, which develops highly optimized algorithms for bioinformatics applications, today announced a technology partnership that will enhance Fabric Genomics’ secondary analysis capabilities within Fabric EnterpriseTM, the company’s new end-to-end precision medicine platform. Fabric Genomics’ new secondary analysis offering, Fabric StandardTM, is 10 times faster than commonly adopted BWA-GATK […]
Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage of genomic data. […]
“It’s another pore excuse for a lawsuit,” said Dr Gordon Sanghera, CEO. ” We believe this is another frivolous lawsuit brought by a competitor nervous about our superior technology. I would like to assure all our customers that this and other actions will not disrupt our commercial operations.” New: GridION – a real time, ultra-long […]
New, Innovative Life Sciences Company Exclusively Licenses Technologies from Brandeis University Waltham, MA ThermaGenix, Inc., a new life sciences company, announces that it has exclusively licensed certain technologies from Brandeis University that significantly enhance detection and analysis of nucleic acids, both DNA and RNA, via the Polymerase Chain Reaction (PCR). These platform technologies are applicable […]
Validated for human identification, the system drives efficiencies and positions casework laboratories for future advancements CARLSBAD, Calif.–Forensic scientists who want to modernize their laboratories now have access to the Applied Biosystems QuantStudio 5 Real-Time PCR System for Human Identification. Paired with the complementary analysis software and Thermo Fisher Scientific’s leading DNA chemistries, the complete solution […]
Leading Experts in Genomic Medicine and Cancer Research are Inaugural Members CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced its Scientific Advisory Board, which formalizes relationships with leading global experts in genomic medicine, bioinformatics and cancer research. Members of the Seven Bridges Scientific Advisory Board will advise on the company’s product designs […]
AUSTIN, Texas − Asuragen, Inc., a global molecular diagnostics company, announced today the availability of the AmplideX® PCR/CE TOMM40 Kit1 for research use only to advance studies of neurodegeneration, dementia progression, and Alzheimer’s disease (AD). AD is the most common cause of dementia worldwide with over 46 million people now living with the disease. These numbers are expected to increase dramatically over […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
